Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1990 Jan 1;171(1):63–73. doi: 10.1084/jem.171.1.63

Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis

PMCID: PMC2187668  PMID: 2295882

Abstract

Immunization with the 69-kD outer membrane protein (OMP) of Bordetella pertussis protected neonatal mice against lethal respiratory challenge with B. pertussis 18323. Active immunization elicited a serum IgG anti- 69-kD OMP response at the time of challenge, with IgG anti-69-kD OMP antibodies detected in bronchoalveolar lavage fluid after challenge. Intravenous administration of BPE8, a monoclonal IgG1 anti-69-kD OMP, also protected young mice against B. pertussis challenge. Intravenously injected BPE8 was detected in the lungs of mice at the time of aerosol challenge, suggesting that the presence of specific antibody in the lungs may mediate protection. Thus the 69-kD OMP of B. pertussis is a protective antigen in mice that elicits specific serum antibody that can transude to the lung. The 69-kD OMP was detected in a preparation of a Takeda acellular vaccine by immunoblot analysis and a serum antibody response to the 69-kD OMP was observed in 18-mo-old children boosted with this preparation of Japanese acellular vaccine. Our results demonstrate that the B. pertussis 69-kD OMP is a protective antigen in animals, is immunogenic in humans, and is present in a preparation of acellular pertussis vaccine that is widely used in Japan. These findings indicate that the 69-kD OMP should be seriously considered as a candidate for inclusion in new formulations of antigenically defined acellular pertussis vaccines.

Full Text

The Full Text of this article is available as a PDF (754.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoyama T., Murase Y., Gonda T., Iwata T. Type-specific efficacy of acellular pertussis vaccine. Am J Dis Child. 1988 Jan;142(1):40–42. doi: 10.1001/archpedi.1988.02150010050019. [DOI] [PubMed] [Google Scholar]
  2. Arciniega J. L., Burns D. L., Garcia-Ortigoza E., Manclark C. R. Immune response to the B oligomer of pertussis toxin. Infect Immun. 1987 May;55(5):1132–1136. doi: 10.1128/iai.55.5.1132-1136.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brennan M. J., Li Z. M., Cowell J. L., Bisher M. E., Steven A. C., Novotny P., Manclark C. R. Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect Immun. 1988 Dec;56(12):3189–3195. doi: 10.1128/iai.56.12.3189-3195.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Charles I. G., Dougan G., Pickard D., Chatfield S., Smith M., Novotny P., Morrissey P., Fairweather N. F. Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussis. Proc Natl Acad Sci U S A. 1989 May;86(10):3554–3558. doi: 10.1073/pnas.86.10.3554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cody C. L., Baraff L. J., Cherry J. D., Marcy S. M., Manclark C. R. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics. 1981 Nov;68(5):650–660. [PubMed] [Google Scholar]
  6. De Magistris M. T., Romano M., Nuti S., Rappuoli R., Tagliabue A. Dissecting human T cell responses against Bordetella species. J Exp Med. 1988 Oct 1;168(4):1351–1362. doi: 10.1084/jem.168.4.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hewlett E. L., Sauer K. T., Myers G. A., Cowell J. L., Guerrant R. L. Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect Immun. 1983 Jun;40(3):1198–1203. doi: 10.1128/iai.40.3.1198-1203.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kenimer J. G., Habig W. H., Hardegree M. C. Monoclonal antibodies as probes of tetanus toxin structure and function. Infect Immun. 1983 Dec;42(3):942–948. doi: 10.1128/iai.42.3.942-948.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kraehenbuhl J. P., Bron C., Sordat B. Transfer of humoral secretory and cellular immunity from mother to offspring. Curr Top Pathol. 1979;66:105–157. doi: 10.1007/978-3-642-67205-7_4. [DOI] [PubMed] [Google Scholar]
  10. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  11. Mallory F. B., Hornor A. A. Pertussis: The histological Lesion in the Respiratory Tract. J Med Res. 1912 Nov;27(2):115–124.3. [PMC free article] [PubMed] [Google Scholar]
  12. Montaraz J. A., Novotny P., Ivanyi J. Identification of a 68-kilodalton protective protein antigen from Bordetella bronchiseptica. Infect Immun. 1985 Mar;47(3):744–751. doi: 10.1128/iai.47.3.744-751.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Noble G. R., Bernier R. H., Esber E. C., Hardegree M. C., Hinman A. R., Klein D., Saah A. J. Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists. JAMA. 1987 Mar 13;257(10):1351–1356. [PubMed] [Google Scholar]
  14. Novotny P., Kobisch M., Cownley K., Chubb A. P., Montaraz J. A. Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay. Infect Immun. 1985 Oct;50(1):190–198. doi: 10.1128/iai.50.1.190-198.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sato Y., Izumiya K., Sato H., Cowell J. L., Manclark C. R. Aerosol infection of mice with Bordetella pertussis. Infect Immun. 1980 Jul;29(1):261–266. doi: 10.1128/iai.29.1.261-266.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Thomas M. G., Redhead K., Lambert H. P. Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination. J Infect Dis. 1989 Feb;159(2):211–218. doi: 10.1093/infdis/159.2.211. [DOI] [PubMed] [Google Scholar]
  17. Toews G. B., Hart D. A., Hansen E. J. Effect of systemic immunization on pulmonary clearance of Haemophilus influenzae type b. Infect Immun. 1985 May;48(2):343–349. doi: 10.1128/iai.48.2.343-349.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Tsai C. M., Frasch C. E. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem. 1982 Jan 1;119(1):115–119. doi: 10.1016/0003-2697(82)90673-x. [DOI] [PubMed] [Google Scholar]
  19. VACCINATION against whooping-cough; relation between protection in children and results of laboratory tests; a report to the Whooping-cough Immunization Committee of the Medical Research Council and to the medical officers of health for Cardiff, Leeds, Leyton, Manchester, Middlesex, Oxford, Poole, Tottenham, Walthamstow, and Wembley. Br Med J. 1956 Aug 25;2(4990):454–462. [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES